CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 295 enrolled
Drug / intervention
BL-3100-NBR03 multi-purpose solution +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05565937
NCT05565937N/ACompleted
CompareCT.gov

A Safety and Effectiveness Study of a Contact Lens Cleaning and Disinfecting Solution

Bausch & Lomb Incorporated·interventional·Posted Oct 4, 2022·Updated May 20, 2025

In Brief

A clinical study evaluating BL-3100-NBR03 multi-purpose solution and renu® Advanced Formula multi-purpose solution for Refractive Ametropia. Completed, enrolled 295 participants across 19 sites.

Detailed Summary

Approximately 340 participants (680 eyes) will be enrolled in this three-month, two-arm, 1:1 randomized, parallel-group, bilateral, double-masked study at approximately 22 investigative sites in the United States. Participants will be required to wear dispensed study lenses on a daily wear basis for three months with scheduled in-office replacement of study lenses at the 1-Month and 2-Month Follow-Up Visits.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Ametropia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 4, 2022
Enrollment StartApr 12, 2023
Primary CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.7 years ago

Interventions

BL-3100-NBR03 multi-purpose solutiondevice

BL-3100-NBR03 multi-purpose solution used to clean and disinfect contact lenses

renu® Advanced Formula multi-purpose solutiondevice

renu® Advanced Formula multi-purpose solution used to clean and disinfect contact lenses